pyrroles has been researched along with Biliary Cirrhosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bainbridge, JD; Caldwell, SH; Chalasani, NP; deLemos, AS; Goldberg, DS; Levy, C; Mena, EA; Parmar, DV; Pyrsopoulos, N; Ravinuthala, R; Rossi, S; Shaikh, F; Sheikh, A; Vuppalanchi, R | 1 |
| González-Huezo, MS; Muñoz-Espinosa, LE; Parmar, D; Payan-Olivas, R; Pio Cruz-Lopez, JL; Shaikh, F; Vuppalanchi, R | 1 |
| Claudel, T; Fauler, G; März, W; Putz-Bankuti, C; Scharnagl, H; Sourij, H; Stauber, RE; Stojakovic, T; Trauner, M; Wagner, M; Wascher, TC; Winkler, K | 1 |
| Fauler, G; Gurakuqi, G; März, W; Putz-Bankuti, C; Scharnagl, H; Stadlbauer, V; Stauber, RE; Stojakovic, T; Trauner, M; Wagner, M | 1 |
| Allina, J; Bach, N; Bodenheimer, H; Bodian, C; Odin, JA; Stanca, CM | 1 |
2 trial(s) available for pyrroles and Biliary Cirrhosis
| Article | Year |
|---|---|
Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis.
Topics: Double-Blind Method; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Phenylpropionates; Placebos; Pyrroles; Treatment Outcome | 2022 |
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
Topics: Atorvastatin; Blood Vessels; Cardiovascular Diseases; Cholestasis; Cholesterol; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Pyrroles | 2010 |
3 other study(ies) available for pyrroles and Biliary Cirrhosis
| Article | Year |
|---|---|
A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Female; Humans; Intention to Treat Analysis; Liver Cirrhosis, Biliary; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; Phenylpropionates; Pyrroles | 2021 |
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholagogues and Choleretics; Cholestasis; Cholesterol; Female; Heptanoic Acids; Humans; Lipoproteins, LDL; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Pyrroles; Single-Blind Method; Transaminases; Ursodeoxycholic Acid | 2007 |
Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Lipids; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Pyrroles; Quality of Life; Retrospective Studies; Treatment Outcome | 2008 |